Continue reading on theverge.com
Continue reading on cnbc.com
Continue reading on reuters.com
business

US, Pfizer reach $3.2B COVID vaccine deal

Jun 30, 2022
US, Pfizer reach $3.2B COVID vaccine deal

Pfizer and BioNTech SE said Wednesday that they had inked a $3.2 billion agreement with the U.S. government for 105 million doses of their COVID-19 vaccine. The deal includes new versions of the sho...

Continue reading on foxbusiness.com
Continue reading on cnbc.com
Continue reading on benzinga.com
Recommended